Daehwa Pharm applies for approval of anti-dementia patch in China

South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...

Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA

Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...

CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn

South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...

Celltrion to develop Humira biosimilar oral medication with US firm

South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...

S.Korea to bolster biotech R&D, benchmarking US' Boston

South Korea is poised to boost the biotech industry by accelerating research, education and business partnerships with the biopharmaceutical sector ...

Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

HanAll, Daewoong to develop Parkinson's treatment with US partner

South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...

Celltrion gets FDA approval for Humira biosimilar CT-P17

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine

South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...

CJ Bioscience conducts paid-in capital increase of $50 mn

South Korea's CJ Bioscience Inc., a pharmaceutical company specializing in intestinal microorganisms called microbiomes, will conduct a paid-in capi...

HLB submits new drug application to FDA for Rivoceranib liver cancer drug

HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...

Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn

South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...

Lemonex signs MOU with WHO mRNA vaccines tech hub

South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...

SK Biopharmaceuticals gets marketing approval for epilepsy drug in Israel

South Korea’s SK Biopharmaceuticals said on Wednesday that the Israeli Ministry of Health has approved the company's new drug application (NDA...

LG Chem in talks with Glenwood to sell off diagnostics unit

LG Chem Ltd. is slated for exclusive talks with Seoul-based Glenwood Private Equity to sell off its in vitro diagnostics business, according to biop...

SK Bioscience to invest $1.8 billion, seeks M&As for inorganic growth

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, plans to spend 2.4 trillion won ($1.8 billion) over the next five years and...

S.Korea's Kainos Medicine exports AIDS treatment technology to China

South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...

GeneOne Life Science gets patent for coated microneedle tech in China

South Korea’s biopharmaceutical company GeneOne Life Science Inc. on Tuesday said it received a patent from the China National Intellectual Pr...

Daewoong Pharma, UK firm to jointly develop autoimmune disease drug

South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...

S.Korea sees release of generic diabetes drugs after Forxiga patent expires

South Korea's pharmaceutical companies are competing to sell generic drugs to raise their presence on the domestic market for diabetes treatment wit...

JW Pharma to use zebrafish in new drug development

South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...

LG Chem to launch new diabetes combination drug Zemidapa

South Korean chemical company LG Chem Ltd. has announced the release of a new diabetes combination drug, Zemidapa Tab, set to launch on Apr. 8. Th...

Drug instructions to be provided via QR codes, URLs in S.Korea

South Korea's the Ministry of Food and Drug Safety announced on Friday that it had revised the "Risk Management Plan (RMP) Guidelines" to allow for ...

Kolon Pharma to merge with anti-cancer drug developer Platbio

Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...

Biosimilar giant Celltrion to transform into drug developer

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

S.Korea's Biorchestra signs tech transfer deal for drug delivery system

Biorchestra Co., a South Korean company specializing in RNA-based therapeutics, announced on Tuesday that it has entered into a joint research and o...

Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK

South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...

Kwangdong introduces new drug candidate for pediatric myopia

South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it has signed a contract with Hong Kong-based Zhaoke Ophthalmo...

JW Pharma receives 1st overseas patent for its hair loss treatment

JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...

S.Korea's ST Pharm supplies $49 mn worth of APIs to European drug firm

ST Pharm Co., a South Korean pharmaceutical firm, announced on Thursday that it had entered into an agreement to supply oligonucleotides to an undis...